Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma
<p>Abstract</p> <p>Background</p> <p>Increase of Serum amyloid A (SAA) level has been observed in patients with a variety of cancers. The objective of this study was to determined whether SAA level could be used as a prognostic parameter in patients with esophageal squa...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-08-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/12/365 |
id |
doaj-14e671074d7e492baceff5a8946dbe74 |
---|---|
record_format |
Article |
spelling |
doaj-14e671074d7e492baceff5a8946dbe742020-11-24T22:50:21ZengBMCBMC Cancer1471-24072012-08-0112136510.1186/1471-2407-12-365Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinomaWang Jun-YeZheng Yu-ZhenYang JuanLin Yue-HaoDai Shu-QinZhang GeLiu Wan-Li<p>Abstract</p> <p>Background</p> <p>Increase of Serum amyloid A (SAA) level has been observed in patients with a variety of cancers. The objective of this study was to determined whether SAA level could be used as a prognostic parameter in patients with esophageal squamous cell carcinoma (ESCC).</p> <p>Methods</p> <p>SAA levels were measured by rate nephelometry immunoassay in 167 healthy controls and 167 ESCC patients prior to surgical resection. Statistical associations between clinicopathological observations and SAA levels were determined using the Mann–Whitney U test. The clinical value of SAA level as a prognostic parameter was evaluated using the Cox’s proportional hazards model.</p> <p>Results</p> <p>SAA levels were significantly higher in patients with ESCC compared to levels in healthy controls (13.88 ± 15.19 mg/L vs. 2.26 ± 1.66 mg/L, <it>P</it> < 0.001). Elevation of SAA levels (≥ 8.0 mg/L) was observed in 54.5% (91/167) of patients with ESCC but not in healthy controls. SAA levels were associated with tumor size (<it>P</it> < 0.001), histological differentiation (<it>P</it> = 0.015), T classification (<it>P</it> < 0.001), clinical stage (<it>P</it> < 0.001), lymph node metastasis (<it>P</it> < 0.001) and distant metastasis (<it>P</it> < 0.001), but not with the age and gender of the patients or tumor location. Multivariate analysis revealed that patients with an elevated level of SAA (≥ 8.0 mg/L) had significantly lower 5-year survival rate than those with non-elevated SAA (< 8.0 mg/L, log-rank <it>P</it> < 0.0001).</p> <p>Conclusions</p> <p>An elevated level of preoperative SAA was found to associate with tumor progression and poor survival in patients with ESCC.</p> http://www.biomedcentral.com/1471-2407/12/365Serum amyloid AEsophageal squamous cell carcinomaPrognosisBiomark |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Wang Jun-Ye Zheng Yu-Zhen Yang Juan Lin Yue-Hao Dai Shu-Qin Zhang Ge Liu Wan-Li |
spellingShingle |
Wang Jun-Ye Zheng Yu-Zhen Yang Juan Lin Yue-Hao Dai Shu-Qin Zhang Ge Liu Wan-Li Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma BMC Cancer Serum amyloid A Esophageal squamous cell carcinoma Prognosis Biomark |
author_facet |
Wang Jun-Ye Zheng Yu-Zhen Yang Juan Lin Yue-Hao Dai Shu-Qin Zhang Ge Liu Wan-Li |
author_sort |
Wang Jun-Ye |
title |
Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma |
title_short |
Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma |
title_full |
Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma |
title_fullStr |
Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma |
title_full_unstemmed |
Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma |
title_sort |
elevated levels of serum amyloid a indicate poor prognosis in patients with esophageal squamous cell carcinoma |
publisher |
BMC |
series |
BMC Cancer |
issn |
1471-2407 |
publishDate |
2012-08-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Increase of Serum amyloid A (SAA) level has been observed in patients with a variety of cancers. The objective of this study was to determined whether SAA level could be used as a prognostic parameter in patients with esophageal squamous cell carcinoma (ESCC).</p> <p>Methods</p> <p>SAA levels were measured by rate nephelometry immunoassay in 167 healthy controls and 167 ESCC patients prior to surgical resection. Statistical associations between clinicopathological observations and SAA levels were determined using the Mann–Whitney U test. The clinical value of SAA level as a prognostic parameter was evaluated using the Cox’s proportional hazards model.</p> <p>Results</p> <p>SAA levels were significantly higher in patients with ESCC compared to levels in healthy controls (13.88 ± 15.19 mg/L vs. 2.26 ± 1.66 mg/L, <it>P</it> < 0.001). Elevation of SAA levels (≥ 8.0 mg/L) was observed in 54.5% (91/167) of patients with ESCC but not in healthy controls. SAA levels were associated with tumor size (<it>P</it> < 0.001), histological differentiation (<it>P</it> = 0.015), T classification (<it>P</it> < 0.001), clinical stage (<it>P</it> < 0.001), lymph node metastasis (<it>P</it> < 0.001) and distant metastasis (<it>P</it> < 0.001), but not with the age and gender of the patients or tumor location. Multivariate analysis revealed that patients with an elevated level of SAA (≥ 8.0 mg/L) had significantly lower 5-year survival rate than those with non-elevated SAA (< 8.0 mg/L, log-rank <it>P</it> < 0.0001).</p> <p>Conclusions</p> <p>An elevated level of preoperative SAA was found to associate with tumor progression and poor survival in patients with ESCC.</p> |
topic |
Serum amyloid A Esophageal squamous cell carcinoma Prognosis Biomark |
url |
http://www.biomedcentral.com/1471-2407/12/365 |
work_keys_str_mv |
AT wangjunye elevatedlevelsofserumamyloidaindicatepoorprognosisinpatientswithesophagealsquamouscellcarcinoma AT zhengyuzhen elevatedlevelsofserumamyloidaindicatepoorprognosisinpatientswithesophagealsquamouscellcarcinoma AT yangjuan elevatedlevelsofserumamyloidaindicatepoorprognosisinpatientswithesophagealsquamouscellcarcinoma AT linyuehao elevatedlevelsofserumamyloidaindicatepoorprognosisinpatientswithesophagealsquamouscellcarcinoma AT daishuqin elevatedlevelsofserumamyloidaindicatepoorprognosisinpatientswithesophagealsquamouscellcarcinoma AT zhangge elevatedlevelsofserumamyloidaindicatepoorprognosisinpatientswithesophagealsquamouscellcarcinoma AT liuwanli elevatedlevelsofserumamyloidaindicatepoorprognosisinpatientswithesophagealsquamouscellcarcinoma |
_version_ |
1725672864668975104 |